Published in Neural Plast on February 09, 2012
Genetic syndromes caused by mutations in epigenetic genes. Hum Genet (2013) 1.11
Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Mol Autism (2013) 0.98
DNA modifications: function and applications in normal and disease States. Biology (Basel) (2014) 0.88
Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS One (2014) 0.87
The genetic and epigenetic journey of embryonic stem cells into mature neural cells. Front Genet (2012) 0.87
Cellular commitment in the developing cerebellum. Front Cell Neurosci (2015) 0.86
Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PLoS One (2012) 0.85
DNA methylation mediates persistent epileptiform activity in vitro and in vivo. PLoS One (2013) 0.83
Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain. Nucleic Acids Res (2013) 0.83
MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity. FEBS Open Bio (2015) 0.80
Structural, Dynamical, and Energetical Consequences of Rett Syndrome Mutation R133C in MeCP2. Comput Math Methods Med (2015) 0.79
TLS/FUS: a protein in cancer and ALS. Cell Cycle (2012) 0.79
Role of mecp2 in experience-dependent epigenetic programming. Genes (Basel) (2015) 0.79
MECP2, a gene associated with Rett syndrome in humans, shows conserved coding regions, independent Alu insertions, and a novel transcript across primate evolution. BMC Genet (2015) 0.78
MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect. Oncotarget (2016) 0.78
Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injury. Epigenetics Chromatin (2016) 0.75
Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins. J Neurodev Disord (2013) 0.75
MeCP2-Related Diseases and Animal Models. Diseases (2014) 0.75
Vimentin-Mediated Steroidogenesis Induced by Phthalate Esters: Involvement of DNA Demethylation and Nuclear Factor κB. PLoS One (2016) 0.75
Differential Regulation of MeCP2 Phosphorylation by Laminin in Oligodendrocytes. J Mol Neurosci (2017) 0.75
MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1. Oncogenesis (2017) 0.75
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Eukaryotic cytosine methyltransferases. Annu Rev Biochem (2005) 15.45
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet (2002) 9.16
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Histone and chromatin cross-talk. Curr Opin Cell Biol (2003) 8.69
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet (2001) 8.64
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
Spheroid chromatin units (v bodies). Science (1974) 8.15
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell (1992) 8.10
The story of Rett syndrome: from clinic to neurobiology. Neuron (2007) 8.08
Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol (1998) 7.61
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Reversal of neurological defects in a mouse model of Rett syndrome. Science (2007) 7.09
Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron (2006) 6.50
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell (1997) 6.45
Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell (2005) 6.17
Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron (2002) 5.71
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet (2004) 5.64
Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell (2010) 5.43
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 5.11
Dynamic binding of histone H1 to chromatin in living cells. Nature (2000) 4.91
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron (2006) 4.74
Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A (2005) 4.59
Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol (2010) 4.03
Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A (2007) 4.00
Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet (2005) 3.87
Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr Opin Cell Biol (2001) 3.86
Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology (2008) 3.74
MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci (2004) 3.48
Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci (2009) 3.42
The DNA glycosylase/lyase ROS1 functions in pruning DNA methylation patterns in Arabidopsis. Curr Biol (2007) 3.33
L1 retrotransposition in neurons is modulated by MeCP2. Nature (2010) 3.25
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A (2009) 3.23
A role for glia in the progression of Rett's syndrome. Nature (2011) 3.18
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet (2002) 3.12
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell (2005) 3.01
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res (1992) 2.99
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A (2005) 2.90
Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet (2004) 2.89
Genomic imprinting determines methylation of parental alleles in transgenic mice. Nature (1987) 2.71
Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods (2009) 2.51
Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci (2009) 2.35
Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet (2005) 2.35
Studies of X chromosome DNA methylation in normal human cells. Nature (1982) 2.34
Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci U S A (2009) 2.30
H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. Mol Cell Biol (2003) 2.29
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A (2007) 2.27
Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2006) 2.25
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem (2003) 2.14
MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet (2001) 2.12
Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology (2008) 2.10
Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics (2006) 2.03
Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet (1998) 1.98
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet (2005) 1.87
Epigenetic control. J Cell Physiol (2009) 1.85
Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A (2009) 1.79
The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res (2004) 1.79
The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J Biol Chem (2002) 1.74
Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet (2001) 1.66
Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet A (2004) 1.63
A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol Cell (2003) 1.61
MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet (2000) 1.58
Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet (2004) 1.56
Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol (2006) 1.52
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet (2007) 1.49
Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology (2000) 1.48
The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem (2001) 1.47
MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet (2001) 1.45
Early progressive encephalopathy in boys and MECP2 mutations. Neurology (2006) 1.44
X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Hum Mol Genet (2004) 1.40
FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet (2007) 1.39
Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet (2001) 1.38
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet (2006) 1.37
Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience (2004) 1.36
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet (2000) 1.34
Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med (Berl) (2002) 1.32
Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis (2001) 1.30
Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci (2008) 1.26
Beyond the double helix: writing and reading the histone code. Novartis Found Symp (2004) 1.25
Rett syndrome: model of neurodevelopmental disorders. J Child Neurol (2005) 1.23
Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci (2003) 1.20
Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm Genome (1996) 1.20
Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol (2007) 1.16
Neonatal encephalopathy in two boys in families with recurrent Rett syndrome. J Child Neurol (1998) 1.16
MeCP2 dysfunction in humans and mice. J Child Neurol (2005) 1.15
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet (2010) 1.10
Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J Neuropathol Exp Neurol (2007) 1.10
MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One (2009) 1.09
MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation. FEBS Lett (2008) 1.09
Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet (2002) 1.06
Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat (2010) 1.06
Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat (2003) 1.04
Linker histone H1 modulates nucleosome remodeling by human SWI/SNF. J Biol Chem (2003) 1.01
Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet (2001) 1.01
Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci (2010) 0.94
Distinct expression profiles of Mecp2 transcripts with different lengths of 3'UTR in the brain and visceral organs during mouse development. Genomics (2005) 0.93
The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome. BMC Neurosci (2011) 0.90
Epigenetic control. J Cell Physiol (2009) 1.85
MEIS C termini harbor transcriptional activation domains that respond to cell signaling. J Biol Chem (2005) 1.11
Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat (2010) 1.06
Retrovirus silencing by an epigenetic TRIM. Cell (2007) 0.99
Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet (2013) 0.98
Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer (2012) 0.88
Beta2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3, -8 and -9 pathways but through increased reactive oxygen species. Int J Cancer (2003) 0.87
Rett syndrome and MeCP2. Neuromolecular Med (2014) 0.87
The genetic and epigenetic journey of embryonic stem cells into mature neural cells. Front Genet (2012) 0.87
Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural differentiation. J Biol Chem (2006) 0.85
Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PLoS One (2012) 0.85
Stereospecificity and PAX6 function direct Hoxd4 neural enhancer activity along the antero-posterior axis. Dev Biol (2006) 0.85
Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells. Ann Anat (2013) 0.84
Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant. Oncogene (2002) 0.78